nodes	percent_of_prediction	percent_of_DWPC	metapath
Glyburide—ABCC3—Vincristine—muscle cancer	0.0667	0.077	CbGbCtD
Glyburide—ABCC1—Dactinomycin—muscle cancer	0.0665	0.0768	CbGbCtD
Glyburide—ABCC3—Etoposide—muscle cancer	0.0612	0.0706	CbGbCtD
Glyburide—ABCB11—Vincristine—muscle cancer	0.0577	0.0666	CbGbCtD
Glyburide—ABCG2—Dactinomycin—muscle cancer	0.0445	0.0514	CbGbCtD
Glyburide—ABCC3—Doxorubicin—muscle cancer	0.0417	0.0481	CbGbCtD
Glyburide—ABCC1—Vincristine—muscle cancer	0.041	0.0473	CbGbCtD
Glyburide—ABCC3—Methotrexate—muscle cancer	0.0404	0.0466	CbGbCtD
Glyburide—ABCC1—Etoposide—muscle cancer	0.0375	0.0433	CbGbCtD
Glyburide—ABCB11—Doxorubicin—muscle cancer	0.036	0.0416	CbGbCtD
Glyburide—SLC22A7—Methotrexate—muscle cancer	0.0316	0.0365	CbGbCtD
Glyburide—ABCC2—Vincristine—muscle cancer	0.0303	0.035	CbGbCtD
Glyburide—ABCC2—Etoposide—muscle cancer	0.0278	0.0321	CbGbCtD
Glyburide—ABCG2—Vincristine—muscle cancer	0.0274	0.0316	CbGbCtD
Glyburide—ABCC1—Doxorubicin—muscle cancer	0.0256	0.0296	CbGbCtD
Glyburide—ABCG2—Etoposide—muscle cancer	0.0251	0.029	CbGbCtD
Glyburide—ABCC1—Methotrexate—muscle cancer	0.0248	0.0286	CbGbCtD
Glyburide—SLCO1A2—Methotrexate—muscle cancer	0.0221	0.0256	CbGbCtD
Glyburide—ABCC2—Doxorubicin—muscle cancer	0.019	0.0219	CbGbCtD
Glyburide—ABCC2—Methotrexate—muscle cancer	0.0184	0.0212	CbGbCtD
Glyburide—ABCG2—Doxorubicin—muscle cancer	0.0171	0.0198	CbGbCtD
Glyburide—ABCG2—Methotrexate—muscle cancer	0.0166	0.0192	CbGbCtD
Glyburide—ABCB1—Dactinomycin—muscle cancer	0.0161	0.0185	CbGbCtD
Glyburide—SLC22A6—Methotrexate—muscle cancer	0.0134	0.0155	CbGbCtD
Glyburide—ALB—Methotrexate—muscle cancer	0.0114	0.0132	CbGbCtD
Glyburide—ABCB1—Vincristine—muscle cancer	0.00989	0.0114	CbGbCtD
Glyburide—ABCB1—Etoposide—muscle cancer	0.00906	0.0105	CbGbCtD
Glyburide—KCNJ1—appendage—muscle cancer	0.00714	0.12	CbGeAlD
Glyburide—ABCB1—Doxorubicin—muscle cancer	0.00618	0.00713	CbGbCtD
Glyburide—ABCB1—Methotrexate—muscle cancer	0.00599	0.00691	CbGbCtD
Glyburide—CYP3A4—Vincristine—muscle cancer	0.00592	0.00684	CbGbCtD
Glyburide—CYP3A4—Etoposide—muscle cancer	0.00543	0.00627	CbGbCtD
Glyburide—CYP3A4—Doxorubicin—muscle cancer	0.0037	0.00427	CbGbCtD
Glyburide—KCNJ5—cardiac atrium—muscle cancer	0.00297	0.0498	CbGeAlD
Glyburide—Gliclazide—VEGFA—muscle cancer	0.00275	1	CrCbGaD
Glyburide—ABCC9—smooth muscle tissue—muscle cancer	0.00262	0.0438	CbGeAlD
Glyburide—KCNJ5—head—muscle cancer	0.00222	0.0372	CbGeAlD
Glyburide—Myelosuppression—Dactinomycin—muscle cancer	0.00217	0.0304	CcSEcCtD
Glyburide—Myelosuppression—Vincristine—muscle cancer	0.00193	0.0272	CcSEcCtD
Glyburide—CPT1A—renal system—muscle cancer	0.00183	0.0307	CbGeAlD
Glyburide—KCNJ1—renal system—muscle cancer	0.00179	0.03	CbGeAlD
Glyburide—ABCA1—renal system—muscle cancer	0.00171	0.0286	CbGeAlD
Glyburide—Eruption—Dactinomycin—muscle cancer	0.00165	0.0232	CcSEcCtD
Glyburide—Blindness—Vincristine—muscle cancer	0.00164	0.023	CcSEcCtD
Glyburide—ABCC9—testis—muscle cancer	0.00163	0.0272	CbGeAlD
Glyburide—CFTR—renal system—muscle cancer	0.00161	0.027	CbGeAlD
Glyburide—Myelosuppression—Etoposide—muscle cancer	0.00157	0.022	CcSEcCtD
Glyburide—Lactic acidosis—Doxorubicin—muscle cancer	0.00156	0.0219	CcSEcCtD
Glyburide—Inappropriate antidiuretic hormone secretion—Vincristine—muscle cancer	0.00156	0.0219	CcSEcCtD
Glyburide—Nephropathy—Etoposide—muscle cancer	0.00154	0.0217	CcSEcCtD
Glyburide—CPT1A—tendon—muscle cancer	0.00143	0.0239	CbGeAlD
Glyburide—Allergic cutaneous angiitis—Methotrexate—muscle cancer	0.00138	0.0195	CcSEcCtD
Glyburide—CPT1A—vagina—muscle cancer	0.00133	0.0222	CbGeAlD
Glyburide—Reaction gastrointestinal—Methotrexate—muscle cancer	0.00132	0.0185	CcSEcCtD
Glyburide—Coagulopathy—Dactinomycin—muscle cancer	0.0013	0.0183	CcSEcCtD
Glyburide—ABCA1—vagina—muscle cancer	0.00124	0.0207	CbGeAlD
Glyburide—CPT1A—head—muscle cancer	0.00123	0.0205	CbGeAlD
Glyburide—KCNJ1—head—muscle cancer	0.0012	0.0201	CbGeAlD
Glyburide—SLC22A7—renal system—muscle cancer	0.00119	0.02	CbGeAlD
Glyburide—CPT1A—testis—muscle cancer	0.00118	0.0198	CbGeAlD
Glyburide—ABCA1—head—muscle cancer	0.00114	0.0191	CbGeAlD
Glyburide—ABCA1—testis—muscle cancer	0.0011	0.0185	CbGeAlD
Glyburide—CFTR—head—muscle cancer	0.00108	0.0181	CbGeAlD
Glyburide—CFTR—testis—muscle cancer	0.00104	0.0174	CbGeAlD
Glyburide—ABCC8—smooth muscle tissue—muscle cancer	0.00104	0.0174	CbGeAlD
Glyburide—ABCC8—renal system—muscle cancer	0.001	0.0168	CbGeAlD
Glyburide—SLC15A1—renal system—muscle cancer	0.000958	0.016	CbGeAlD
Glyburide—Aplastic anaemia—Dactinomycin—muscle cancer	0.000953	0.0134	CcSEcCtD
Glyburide—Nephropathy—Methotrexate—muscle cancer	0.000925	0.013	CcSEcCtD
Glyburide—Leukocytoclastic vasculitis—Methotrexate—muscle cancer	0.000898	0.0126	CcSEcCtD
Glyburide—ABCB11—testis—muscle cancer	0.000855	0.0143	CbGeAlD
Glyburide—KCNJ11—tendon—muscle cancer	0.000849	0.0142	CbGeAlD
Glyburide—ABCC3—renal system—muscle cancer	0.000842	0.0141	CbGeAlD
Glyburide—Hepatic failure—Dactinomycin—muscle cancer	0.00082	0.0115	CcSEcCtD
Glyburide—Myelosuppression—Doxorubicin—muscle cancer	0.000813	0.0114	CcSEcCtD
Glyburide—Kidney function abnormal—Doxorubicin—muscle cancer	0.000789	0.0111	CcSEcCtD
Glyburide—SLCO2B1—renal system—muscle cancer	0.000784	0.0131	CbGeAlD
Glyburide—SLC22A7—testis—muscle cancer	0.000771	0.0129	CbGeAlD
Glyburide—Deafness—Vincristine—muscle cancer	0.000736	0.0103	CcSEcCtD
Glyburide—Hepatic failure—Vincristine—muscle cancer	0.000733	0.0103	CcSEcCtD
Glyburide—KCNJ11—head—muscle cancer	0.000728	0.0122	CbGeAlD
Glyburide—SLCO1A2—renal system—muscle cancer	0.000722	0.0121	CbGeAlD
Glyburide—Eruption—Methotrexate—muscle cancer	0.000716	0.0101	CcSEcCtD
Glyburide—SLC15A1—vagina—muscle cancer	0.000694	0.0116	CbGeAlD
Glyburide—Blindness—Doxorubicin—muscle cancer	0.000688	0.00968	CcSEcCtD
Glyburide—Encephalopathy—Methotrexate—muscle cancer	0.000686	0.00964	CcSEcCtD
Glyburide—ABCC2—renal system—muscle cancer	0.000672	0.0113	CbGeAlD
Glyburide—ABCC8—head—muscle cancer	0.000671	0.0112	CbGeAlD
Glyburide—Hyponatraemia—Vincristine—muscle cancer	0.000661	0.00929	CcSEcCtD
Glyburide—ABCC8—testis—muscle cancer	0.000648	0.0108	CbGeAlD
Glyburide—Eruption—Doxorubicin—muscle cancer	0.00062	0.00871	CcSEcCtD
Glyburide—SLCO2B1—tendon—muscle cancer	0.000612	0.0103	CbGeAlD
Glyburide—Pancytopenia—Dactinomycin—muscle cancer	0.000605	0.0085	CcSEcCtD
Glyburide—SLC15A2—renal system—muscle cancer	0.000599	0.01	CbGeAlD
Glyburide—ABCC3—head—muscle cancer	0.000563	0.00943	CbGeAlD
Glyburide—ABCC3—testis—muscle cancer	0.000544	0.00911	CbGeAlD
Glyburide—Pancytopenia—Vincristine—muscle cancer	0.000541	0.0076	CcSEcCtD
Glyburide—ABCC1—cardiac atrium—muscle cancer	0.00053	0.00888	CbGeAlD
Glyburide—Agranulocytosis—Dactinomycin—muscle cancer	0.00053	0.00745	CcSEcCtD
Glyburide—ABCC2—tendon—muscle cancer	0.000525	0.00879	CbGeAlD
Glyburide—SLCO2B1—head—muscle cancer	0.000525	0.00879	CbGeAlD
Glyburide—Photosensitivity reaction—Vincristine—muscle cancer	0.00052	0.0073	CcSEcCtD
Glyburide—Hepatitis—Dactinomycin—muscle cancer	0.00051	0.00717	CcSEcCtD
Glyburide—SLCO2B1—testis—muscle cancer	0.000507	0.00849	CbGeAlD
Glyburide—Hyperbilirubinaemia—Methotrexate—muscle cancer	0.000484	0.0068	CcSEcCtD
Glyburide—SLCO1A2—head—muscle cancer	0.000483	0.00809	CbGeAlD
Glyburide—SLCO1A2—testis—muscle cancer	0.000467	0.00781	CbGeAlD
Glyburide—ALB—testis—muscle cancer	0.000464	0.00777	CbGeAlD
Glyburide—ABCC1—tendon—muscle cancer	0.000462	0.00774	CbGeAlD
Glyburide—Vasculitis—Methotrexate—muscle cancer	0.000451	0.00634	CcSEcCtD
Glyburide—Alopecia—Dactinomycin—muscle cancer	0.000451	0.00633	CcSEcCtD
Glyburide—Sweating increased—Etoposide—muscle cancer	0.000449	0.00631	CcSEcCtD
Glyburide—Erythema—Dactinomycin—muscle cancer	0.000444	0.00624	CcSEcCtD
Glyburide—Pancytopenia—Etoposide—muscle cancer	0.000438	0.00615	CcSEcCtD
Glyburide—ABCC2—testis—muscle cancer	0.000435	0.00728	CbGeAlD
Glyburide—SLC15A2—vagina—muscle cancer	0.000434	0.00727	CbGeAlD
Glyburide—Jaundice cholestatic—Doxorubicin—muscle cancer	0.000434	0.0061	CcSEcCtD
Glyburide—ABCC1—vagina—muscle cancer	0.000429	0.00718	CbGeAlD
Glyburide—Hyperbilirubinaemia—Doxorubicin—muscle cancer	0.000419	0.00589	CcSEcCtD
Glyburide—CYP2C19—vagina—muscle cancer	0.000419	0.00701	CbGeAlD
Glyburide—Aplastic anaemia—Methotrexate—muscle cancer	0.000413	0.00581	CcSEcCtD
Glyburide—Anaemia—Dactinomycin—muscle cancer	0.00041	0.00577	CcSEcCtD
Glyburide—Alopecia—Vincristine—muscle cancer	0.000403	0.00566	CcSEcCtD
Glyburide—SLC15A2—head—muscle cancer	0.000401	0.00671	CbGeAlD
Glyburide—Jaundice—Etoposide—muscle cancer	0.000401	0.00563	CcSEcCtD
Glyburide—Leukopenia—Dactinomycin—muscle cancer	0.000397	0.00558	CcSEcCtD
Glyburide—SLC15A2—testis—muscle cancer	0.000387	0.00648	CbGeAlD
Glyburide—Agranulocytosis—Etoposide—muscle cancer	0.000384	0.00539	CcSEcCtD
Glyburide—ABCC1—testis—muscle cancer	0.000383	0.00641	CbGeAlD
Glyburide—Myalgia—Dactinomycin—muscle cancer	0.000378	0.00531	CcSEcCtD
Glyburide—ABCG2—bone marrow—muscle cancer	0.000371	0.00621	CbGeAlD
Glyburide—Anaemia—Vincristine—muscle cancer	0.000367	0.00515	CcSEcCtD
Glyburide—Oedema—Dactinomycin—muscle cancer	0.000362	0.00509	CcSEcCtD
Glyburide—Aplastic anaemia—Doxorubicin—muscle cancer	0.000358	0.00503	CcSEcCtD
Glyburide—Hepatic failure—Methotrexate—muscle cancer	0.000356	0.005	CcSEcCtD
Glyburide—ABCG2—vagina—muscle cancer	0.000355	0.00595	CbGeAlD
Glyburide—Leukopenia—Vincristine—muscle cancer	0.000355	0.00499	CcSEcCtD
Glyburide—Thrombocytopenia—Dactinomycin—muscle cancer	0.000355	0.00498	CcSEcCtD
Glyburide—Renal failure acute—Methotrexate—muscle cancer	0.000346	0.00486	CcSEcCtD
Glyburide—Anorexia—Dactinomycin—muscle cancer	0.000345	0.00485	CcSEcCtD
Glyburide—Eye disorder—Etoposide—muscle cancer	0.000345	0.00485	CcSEcCtD
Glyburide—Convulsion—Vincristine—muscle cancer	0.000344	0.00483	CcSEcCtD
Glyburide—CYP3A4—renal system—muscle cancer	0.000342	0.00572	CbGeAlD
Glyburide—Myalgia—Vincristine—muscle cancer	0.000338	0.00474	CcSEcCtD
Glyburide—Visual disturbance—Methotrexate—muscle cancer	0.000337	0.00474	CcSEcCtD
Glyburide—Musculoskeletal discomfort—Dactinomycin—muscle cancer	0.00033	0.00464	CcSEcCtD
Glyburide—Alopecia—Etoposide—muscle cancer	0.000326	0.00458	CcSEcCtD
Glyburide—Oedema—Vincristine—muscle cancer	0.000324	0.00455	CcSEcCtD
Glyburide—ABCB1—embryo—muscle cancer	0.000319	0.00535	CbGeAlD
Glyburide—Nervous system disorder—Vincristine—muscle cancer	0.000317	0.00446	CcSEcCtD
Glyburide—ABCG2—testis—muscle cancer	0.000317	0.00531	CbGeAlD
Glyburide—Thrombocytopenia—Vincristine—muscle cancer	0.000317	0.00445	CcSEcCtD
Glyburide—Hepatic function abnormal—Doxorubicin—muscle cancer	0.000317	0.00445	CcSEcCtD
Glyburide—Decreased appetite—Dactinomycin—muscle cancer	0.000315	0.00443	CcSEcCtD
Glyburide—Hyperhidrosis—Vincristine—muscle cancer	0.000313	0.0044	CcSEcCtD
Glyburide—Vascular purpura—Doxorubicin—muscle cancer	0.000309	0.00435	CcSEcCtD
Glyburide—Anorexia—Vincristine—muscle cancer	0.000309	0.00434	CcSEcCtD
Glyburide—Hepatic failure—Doxorubicin—muscle cancer	0.000308	0.00433	CcSEcCtD
Glyburide—Hypotension—Vincristine—muscle cancer	0.000302	0.00425	CcSEcCtD
Glyburide—Renal failure acute—Doxorubicin—muscle cancer	0.0003	0.00421	CcSEcCtD
Glyburide—Feeling abnormal—Dactinomycin—muscle cancer	0.000299	0.0042	CcSEcCtD
Glyburide—Anaemia—Etoposide—muscle cancer	0.000297	0.00417	CcSEcCtD
Glyburide—Gastrointestinal pain—Dactinomycin—muscle cancer	0.000296	0.00416	CcSEcCtD
Glyburide—Musculoskeletal discomfort—Vincristine—muscle cancer	0.000295	0.00414	CcSEcCtD
Glyburide—Renal impairment—Doxorubicin—muscle cancer	0.000291	0.00409	CcSEcCtD
Glyburide—Paraesthesia—Vincristine—muscle cancer	0.000291	0.00408	CcSEcCtD
Glyburide—Dermatitis bullous—Doxorubicin—muscle cancer	0.00029	0.00407	CcSEcCtD
Glyburide—Leukopenia—Etoposide—muscle cancer	0.000288	0.00404	CcSEcCtD
Glyburide—Purpura—Doxorubicin—muscle cancer	0.000287	0.00403	CcSEcCtD
Glyburide—Abdominal pain—Dactinomycin—muscle cancer	0.000286	0.00402	CcSEcCtD
Glyburide—Hypoglycaemia—Doxorubicin—muscle cancer	0.000284	0.00398	CcSEcCtD
Glyburide—Decreased appetite—Vincristine—muscle cancer	0.000281	0.00395	CcSEcCtD
Glyburide—Gastrointestinal disorder—Vincristine—muscle cancer	0.000279	0.00393	CcSEcCtD
Glyburide—Convulsion—Etoposide—muscle cancer	0.000278	0.00391	CcSEcCtD
Glyburide—Hyponatraemia—Doxorubicin—muscle cancer	0.000278	0.0039	CcSEcCtD
Glyburide—Diplopia—Doxorubicin—muscle cancer	0.000277	0.00389	CcSEcCtD
Glyburide—Eosinophilia—Methotrexate—muscle cancer	0.000273	0.00384	CcSEcCtD
Glyburide—Pancreatitis—Methotrexate—muscle cancer	0.000271	0.00381	CcSEcCtD
Glyburide—Hypersensitivity—Dactinomycin—muscle cancer	0.000267	0.00375	CcSEcCtD
Glyburide—Gastrointestinal pain—Vincristine—muscle cancer	0.000265	0.00372	CcSEcCtD
Glyburide—Confusional state—Etoposide—muscle cancer	0.000264	0.00372	CcSEcCtD
Glyburide—Pancytopenia—Methotrexate—muscle cancer	0.000262	0.00369	CcSEcCtD
Glyburide—Asthenia—Dactinomycin—muscle cancer	0.00026	0.00365	CcSEcCtD
Glyburide—Thrombocytopenia—Etoposide—muscle cancer	0.000257	0.00361	CcSEcCtD
Glyburide—Abdominal pain—Vincristine—muscle cancer	0.000256	0.0036	CcSEcCtD
Glyburide—Hyperhidrosis—Etoposide—muscle cancer	0.000253	0.00356	CcSEcCtD
Glyburide—Photosensitivity reaction—Methotrexate—muscle cancer	0.000252	0.00354	CcSEcCtD
Glyburide—Anorexia—Etoposide—muscle cancer	0.00025	0.00351	CcSEcCtD
Glyburide—Diarrhoea—Dactinomycin—muscle cancer	0.000248	0.00348	CcSEcCtD
Glyburide—Hypotension—Etoposide—muscle cancer	0.000245	0.00344	CcSEcCtD
Glyburide—ABCB1—renal system—muscle cancer	0.000242	0.00405	CbGeAlD
Glyburide—Abdominal distension—Doxorubicin—muscle cancer	0.000241	0.00338	CcSEcCtD
Glyburide—Hypersensitivity—Vincristine—muscle cancer	0.000238	0.00335	CcSEcCtD
Glyburide—Eosinophilia—Doxorubicin—muscle cancer	0.000237	0.00333	CcSEcCtD
Glyburide—Paraesthesia—Etoposide—muscle cancer	0.000235	0.00331	CcSEcCtD
Glyburide—Pancreatitis—Doxorubicin—muscle cancer	0.000234	0.00329	CcSEcCtD
Glyburide—Dyspnoea—Etoposide—muscle cancer	0.000234	0.00329	CcSEcCtD
Glyburide—Asthenia—Vincristine—muscle cancer	0.000232	0.00326	CcSEcCtD
Glyburide—Vomiting—Dactinomycin—muscle cancer	0.00023	0.00324	CcSEcCtD
Glyburide—Agranulocytosis—Methotrexate—muscle cancer	0.00023	0.00323	CcSEcCtD
Glyburide—Rash—Dactinomycin—muscle cancer	0.000228	0.00321	CcSEcCtD
Glyburide—Decreased appetite—Etoposide—muscle cancer	0.000228	0.0032	CcSEcCtD
Glyburide—Pancytopenia—Doxorubicin—muscle cancer	0.000227	0.00319	CcSEcCtD
Glyburide—Gastrointestinal disorder—Etoposide—muscle cancer	0.000226	0.00318	CcSEcCtD
Glyburide—Diarrhoea—Vincristine—muscle cancer	0.000221	0.00311	CcSEcCtD
Glyburide—Hepatitis—Methotrexate—muscle cancer	0.000221	0.00311	CcSEcCtD
Glyburide—Photosensitivity reaction—Doxorubicin—muscle cancer	0.000218	0.00307	CcSEcCtD
Glyburide—Feeling abnormal—Etoposide—muscle cancer	0.000216	0.00304	CcSEcCtD
Glyburide—Nausea—Dactinomycin—muscle cancer	0.000215	0.00302	CcSEcCtD
Glyburide—Gastrointestinal pain—Etoposide—muscle cancer	0.000214	0.00301	CcSEcCtD
Glyburide—Visual impairment—Methotrexate—muscle cancer	0.000213	0.00299	CcSEcCtD
Glyburide—Urticaria—Etoposide—muscle cancer	0.000208	0.00293	CcSEcCtD
Glyburide—Jaundice—Doxorubicin—muscle cancer	0.000208	0.00292	CcSEcCtD
Glyburide—Abdominal pain—Etoposide—muscle cancer	0.000207	0.00291	CcSEcCtD
Glyburide—Eye disorder—Methotrexate—muscle cancer	0.000207	0.0029	CcSEcCtD
Glyburide—Vomiting—Vincristine—muscle cancer	0.000206	0.00289	CcSEcCtD
Glyburide—Rash—Vincristine—muscle cancer	0.000204	0.00287	CcSEcCtD
Glyburide—Dermatitis—Vincristine—muscle cancer	0.000204	0.00287	CcSEcCtD
Glyburide—Headache—Vincristine—muscle cancer	0.000203	0.00285	CcSEcCtD
Glyburide—Agranulocytosis—Doxorubicin—muscle cancer	0.000199	0.0028	CcSEcCtD
Glyburide—Alopecia—Methotrexate—muscle cancer	0.000195	0.00275	CcSEcCtD
Glyburide—Hypersensitivity—Etoposide—muscle cancer	0.000193	0.00271	CcSEcCtD
Glyburide—Erythema—Methotrexate—muscle cancer	0.000192	0.0027	CcSEcCtD
Glyburide—Malnutrition—Methotrexate—muscle cancer	0.000192	0.0027	CcSEcCtD
Glyburide—Nausea—Vincristine—muscle cancer	0.000192	0.0027	CcSEcCtD
Glyburide—Hepatitis—Doxorubicin—muscle cancer	0.000191	0.00269	CcSEcCtD
Glyburide—Asthenia—Etoposide—muscle cancer	0.000188	0.00264	CcSEcCtD
Glyburide—Pruritus—Etoposide—muscle cancer	0.000186	0.00261	CcSEcCtD
Glyburide—Visual impairment—Doxorubicin—muscle cancer	0.000184	0.00259	CcSEcCtD
Glyburide—ABCB1—bone marrow—muscle cancer	0.000183	0.00306	CbGeAlD
Glyburide—Vision blurred—Methotrexate—muscle cancer	0.000181	0.00255	CcSEcCtD
Glyburide—Diarrhoea—Etoposide—muscle cancer	0.000179	0.00252	CcSEcCtD
Glyburide—Eye disorder—Doxorubicin—muscle cancer	0.000179	0.00251	CcSEcCtD
Glyburide—Anaemia—Methotrexate—muscle cancer	0.000178	0.0025	CcSEcCtD
Glyburide—ABCB1—vagina—muscle cancer	0.000175	0.00293	CbGeAlD
Glyburide—Leukopenia—Methotrexate—muscle cancer	0.000172	0.00242	CcSEcCtD
Glyburide—Alopecia—Doxorubicin—muscle cancer	0.000169	0.00238	CcSEcCtD
Glyburide—Convulsion—Methotrexate—muscle cancer	0.000167	0.00234	CcSEcCtD
Glyburide—Vomiting—Etoposide—muscle cancer	0.000167	0.00234	CcSEcCtD
Glyburide—Erythema—Doxorubicin—muscle cancer	0.000167	0.00234	CcSEcCtD
Glyburide—Malnutrition—Doxorubicin—muscle cancer	0.000167	0.00234	CcSEcCtD
Glyburide—Rash—Etoposide—muscle cancer	0.000165	0.00232	CcSEcCtD
Glyburide—Dermatitis—Etoposide—muscle cancer	0.000165	0.00232	CcSEcCtD
Glyburide—Headache—Etoposide—muscle cancer	0.000164	0.00231	CcSEcCtD
Glyburide—Myalgia—Methotrexate—muscle cancer	0.000164	0.0023	CcSEcCtD
Glyburide—Arthralgia—Methotrexate—muscle cancer	0.000164	0.0023	CcSEcCtD
Glyburide—ABCB1—head—muscle cancer	0.000162	0.00271	CbGeAlD
Glyburide—Confusional state—Methotrexate—muscle cancer	0.000158	0.00223	CcSEcCtD
Glyburide—Vision blurred—Doxorubicin—muscle cancer	0.000157	0.00221	CcSEcCtD
Glyburide—ABCB1—testis—muscle cancer	0.000156	0.00262	CbGeAlD
Glyburide—Nausea—Etoposide—muscle cancer	0.000156	0.00219	CcSEcCtD
Glyburide—Nervous system disorder—Methotrexate—muscle cancer	0.000154	0.00216	CcSEcCtD
Glyburide—Anaemia—Doxorubicin—muscle cancer	0.000154	0.00216	CcSEcCtD
Glyburide—Thrombocytopenia—Methotrexate—muscle cancer	0.000154	0.00216	CcSEcCtD
Glyburide—Hyperhidrosis—Methotrexate—muscle cancer	0.000152	0.00213	CcSEcCtD
Glyburide—Anorexia—Methotrexate—muscle cancer	0.00015	0.0021	CcSEcCtD
Glyburide—Leukopenia—Doxorubicin—muscle cancer	0.000149	0.0021	CcSEcCtD
Glyburide—Hypotension—Methotrexate—muscle cancer	0.000147	0.00206	CcSEcCtD
Glyburide—Convulsion—Doxorubicin—muscle cancer	0.000144	0.00203	CcSEcCtD
Glyburide—Musculoskeletal discomfort—Methotrexate—muscle cancer	0.000143	0.00201	CcSEcCtD
Glyburide—Arthralgia—Doxorubicin—muscle cancer	0.000142	0.00199	CcSEcCtD
Glyburide—Myalgia—Doxorubicin—muscle cancer	0.000142	0.00199	CcSEcCtD
Glyburide—Paraesthesia—Methotrexate—muscle cancer	0.000141	0.00198	CcSEcCtD
Glyburide—Dyspnoea—Methotrexate—muscle cancer	0.00014	0.00197	CcSEcCtD
Glyburide—Dyspepsia—Methotrexate—muscle cancer	0.000138	0.00194	CcSEcCtD
Glyburide—Confusional state—Doxorubicin—muscle cancer	0.000137	0.00193	CcSEcCtD
Glyburide—Decreased appetite—Methotrexate—muscle cancer	0.000137	0.00192	CcSEcCtD
Glyburide—Oedema—Doxorubicin—muscle cancer	0.000136	0.00191	CcSEcCtD
Glyburide—Gastrointestinal disorder—Methotrexate—muscle cancer	0.000136	0.00191	CcSEcCtD
Glyburide—Shock—Doxorubicin—muscle cancer	0.000134	0.00188	CcSEcCtD
Glyburide—Nervous system disorder—Doxorubicin—muscle cancer	0.000133	0.00187	CcSEcCtD
Glyburide—Thrombocytopenia—Doxorubicin—muscle cancer	0.000133	0.00187	CcSEcCtD
Glyburide—Hyperhidrosis—Doxorubicin—muscle cancer	0.000131	0.00185	CcSEcCtD
Glyburide—Anorexia—Doxorubicin—muscle cancer	0.00013	0.00182	CcSEcCtD
Glyburide—Feeling abnormal—Methotrexate—muscle cancer	0.000129	0.00182	CcSEcCtD
Glyburide—Gastrointestinal pain—Methotrexate—muscle cancer	0.000128	0.0018	CcSEcCtD
Glyburide—Hypotension—Doxorubicin—muscle cancer	0.000127	0.00179	CcSEcCtD
Glyburide—Urticaria—Methotrexate—muscle cancer	0.000125	0.00175	CcSEcCtD
Glyburide—Abdominal pain—Methotrexate—muscle cancer	0.000124	0.00174	CcSEcCtD
Glyburide—Musculoskeletal discomfort—Doxorubicin—muscle cancer	0.000124	0.00174	CcSEcCtD
Glyburide—Paraesthesia—Doxorubicin—muscle cancer	0.000122	0.00172	CcSEcCtD
Glyburide—Dyspnoea—Doxorubicin—muscle cancer	0.000121	0.0017	CcSEcCtD
Glyburide—Dyspepsia—Doxorubicin—muscle cancer	0.00012	0.00168	CcSEcCtD
Glyburide—Decreased appetite—Doxorubicin—muscle cancer	0.000118	0.00166	CcSEcCtD
Glyburide—Gastrointestinal disorder—Doxorubicin—muscle cancer	0.000117	0.00165	CcSEcCtD
Glyburide—Hypersensitivity—Methotrexate—muscle cancer	0.000116	0.00163	CcSEcCtD
Glyburide—Asthenia—Methotrexate—muscle cancer	0.000113	0.00158	CcSEcCtD
Glyburide—Feeling abnormal—Doxorubicin—muscle cancer	0.000112	0.00157	CcSEcCtD
Glyburide—Gastrointestinal pain—Doxorubicin—muscle cancer	0.000111	0.00156	CcSEcCtD
Glyburide—Pruritus—Methotrexate—muscle cancer	0.000111	0.00156	CcSEcCtD
Glyburide—Urticaria—Doxorubicin—muscle cancer	0.000108	0.00152	CcSEcCtD
Glyburide—Abdominal pain—Doxorubicin—muscle cancer	0.000108	0.00151	CcSEcCtD
Glyburide—Diarrhoea—Methotrexate—muscle cancer	0.000107	0.00151	CcSEcCtD
Glyburide—Hypersensitivity—Doxorubicin—muscle cancer	0.0001	0.00141	CcSEcCtD
Glyburide—Vomiting—Methotrexate—muscle cancer	9.99e-05	0.0014	CcSEcCtD
Glyburide—Rash—Methotrexate—muscle cancer	9.9e-05	0.00139	CcSEcCtD
Glyburide—Dermatitis—Methotrexate—muscle cancer	9.89e-05	0.00139	CcSEcCtD
Glyburide—Headache—Methotrexate—muscle cancer	9.84e-05	0.00138	CcSEcCtD
Glyburide—Asthenia—Doxorubicin—muscle cancer	9.76e-05	0.00137	CcSEcCtD
Glyburide—Pruritus—Doxorubicin—muscle cancer	9.62e-05	0.00135	CcSEcCtD
Glyburide—Nausea—Methotrexate—muscle cancer	9.33e-05	0.00131	CcSEcCtD
Glyburide—Diarrhoea—Doxorubicin—muscle cancer	9.3e-05	0.00131	CcSEcCtD
Glyburide—Vomiting—Doxorubicin—muscle cancer	8.65e-05	0.00122	CcSEcCtD
Glyburide—Rash—Doxorubicin—muscle cancer	8.57e-05	0.0012	CcSEcCtD
Glyburide—Dermatitis—Doxorubicin—muscle cancer	8.57e-05	0.0012	CcSEcCtD
Glyburide—Headache—Doxorubicin—muscle cancer	8.52e-05	0.0012	CcSEcCtD
Glyburide—Nausea—Doxorubicin—muscle cancer	8.08e-05	0.00114	CcSEcCtD
